Latest news about Panchsheel Organics
Panchsheel Organics
104.00
-2.00(-1.89%)
Company Performance:
View Company Insights1D-1.89%
1M-1.38%
6M-8.52%
1Y-23.81%
5Y0.00%
More news about Panchsheel Organics
01Jun 26
Panchsheel Organics publishes audited FY26 results
Panchsheel Organics Limited published its audited financial results for the year ended March 31, 2026, in newspapers on June 1, 2026. The company reported a decline in net profit to ₹1,083.04 lakh for FY26 from ₹1,379.45 lakh in the previous year, while revenue from operations stood at ₹10,678.26 lakh. The board recommended a final dividend of ₹0.80 per share and fixed June 12, 2026, as the record date for shareholder eligibility.
12Apr 26
Panchsheel Organics Limited Submits SEBI Compliance Certificate for Q4 FY26
Panchsheel Organics Limited filed its SEBI Regulation 74(5) compliance certificate for Q4 FY26 on April 09, 2026. The certificate, processed through registrar Purva Sharegistry, confirms proper handling of 1,900 dematerialised shares across five transactions between January and March 2026. All securities were confirmed to depositories within prescribed timelines, with certificates properly mutilated and cancelled after verification, demonstrating regulatory compliance.
14Feb 26
Panchsheel Organics Declares ₹0.80 Interim Dividend with Record Date February 20
Panchsheel Organics Limited has declared an interim dividend of ₹0.80 per share following its board meeting on February 14, 2026, representing 8% of paid-up share capital with record date set for February 20, 2026. The company reported Q3FY26 revenue of ₹2,673.20 lakh and net profit of ₹367.75 lakh, showing modest growth compared to the previous year.
18Aug 25
Panchsheel Organics Declares Rs. 0.80 Per Share Interim Dividend
Panchsheel Organics Limited has declared an interim dividend of Rs. 0.80 per equity share, representing 8% of the company's paid-up share capital. The record date is set for August 22, 2025, and payment will be made within 30 days of declaration. The dividend amount is based on a face value of Rs. 10.00 per share. Mahendra A. Turakhia, Managing Director, confirmed these details in a regulatory filing in compliance with SEBI regulations.
Industry Peers
Sun Pharmaceutical
Divis Laboratories
Torrent Pharmaceuticals
Laurus Labs
Zydus Life Science
Cipla
Dr Reddys Laboratories
Aurobindo Pharma
Mankind Pharma
Lupin
1,743.00
(-0.90%)
9,087.00
(-0.63%)
4,558.70
(+0.00%)
2,069.00
(+0.43%)
1,113.90
(-0.81%)
1,324.10
(-0.08%)
1,242.50
(+0.77%)
1,621.40
(-2.73%)
2,253.20
(-0.98%)
1,939.20
(-1.14%)
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
